Skip to main content

Lifevantage Corp

Data quality: 100%
LFVN
Nasdaq Manufacturing Chemicals
$4.01
▼ $0.06 (-1.47%)
Mkt Cap: 51.30 M
Price
$4.01
Mkt Cap
51.30 M
Day Range
$3.90 — $4.19
52-Week Range
$3.90 — $15.29
Volume
62,816
Open $4.10
50D / 200D Avg
$4.91
18.26% below
50D / 200D Avg
$8.54
53.05% below

Quick Summary

Key Takeaways

Revenue grew 0.93% annually over 5 years — modest growth
Earnings grew 233.84% over the past year
ROE of 23.77% indicates high profitability
Generating 1.70 M in free cash flow
P/E of 6.53 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 13.24%

Growth

Revenue Growth (5Y)
0.93%
Below sector avg (9.35%)
Revenue (1Y)14.17%
Earnings (1Y)233.84%
FCF Growth (3Y)67.14%

Quality

Return on Equity
23.77%
Above sector avg (-51.02%)
ROIC17.85%
Net Margin3.74%
Op. Margin4.26%

Safety

Debt / Equity
N/A
Current Ratio2.03
Interest CoverageN/A

Valuation

PE (TTM)
6.53
Above sector avg (-1.98)
P/B Ratio1.56
EV/EBITDA4.32
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E 6.5 -2.0
P/B 1.6 5.1
ROE % 23.8 -51.0
Net Margin % 3.7 -150.2
Rev Growth 5Y % 0.9 9.3
D/E 0.3

ETFs Holding This Stock

SQLV logo SQLV Royce Quant Small-Cap Quality Value ETF
0.23% weight
DES logo DES WisdomTree U.S. SmallCap Dividend Fund
0.03% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.02% weight
BSVO logo BSVO EA Bridgeway Omni Small-Cap Value ETF
0.01% weight
AVUV logo AVUV Avantis U.S. Small Cap Value ETF
0.01% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0.00% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y) 14.17% Revenue Growth (3Y) 3.48%
Earnings Growth (1Y) 233.84% Earnings Growth (3Y) 96.47%
Revenue Growth (5Y) 0.93% Earnings Growth (5Y) -6.62%
Profitability
Revenue (TTM) 210.05 M Net Income (TTM) 7.86 M
ROE 23.77% ROA 12.81%
Gross Margin 78.75% Operating Margin 4.26%
Net Margin 3.74% Free Cash Flow (TTM) 1.70 M
ROIC 17.85% FCF Growth (3Y) 67.14%
Safety
Debt / Equity N/A Current Ratio 2.03
Interest Coverage N/A Asset Turnover 3.42
Working Capital 19.54 M Tangible Book Value 29.20 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 6.53 Forward P/E N/A
P/B Ratio 1.56 P/S Ratio 0.24
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 4.32 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 3.30%
Market Cap 51.30 M Enterprise Value 51.30 M
Per Share
EPS (Diluted TTM) 0.60 Revenue / Share 16.42
FCF / Share 0.13 OCF / Share 0.29
EPS CAGR (1Y) 226.09% EPS CAGR (5Y) -4.46%
EPS CAGR (10Y) 6.94%
Efficiency
CapEx / Revenue 0.98% FCF Conversion 21.56%
SBC-Adj. FCF -2.12 M Growth Momentum 13.24

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 228.53 M 200.16 M 213.40 M 206.36 M 220.18 M
Net Income 9.81 M 2.94 M 2.54 M 3.12 M 12.89 M
EPS (Diluted) 0.75 0.23 0.20 0.24 0.90
Gross Profit 183.67 M 158.72 M 170.01 M 168.26 M 181.99 M
Operating Income 12.20 M 4.33 M 4.26 M 7.58 M 17.62 M
EBITDA
R&D Expenses 1.40 M 700,000.0 600,000.0 700,000.0 700,000.0
SG&A Expenses 69.21 M 68.47 M 71.07 M 63.43 M 60.84 M
D&A 3.16 M 3.58 M 3.58 M 3.26 M 3.46 M
Interest Expense -430,000.0 -198,000.0 10,000.0 17,000.0
Income Tax 2.44 M 1.41 M 1.46 M 1.57 M 4.34 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 71.96 M 60.30 M 66.12 M 70.71 M 78.73 M
Total Liabilities 37.32 M 34.31 M 31.47 M 39.19 M 41.93 M
Shareholders' Equity 34.64 M 25.99 M 34.65 M 31.52 M 36.81 M
Total Debt
Cash & Equivalents 20.20 M 16.89 M 21.61 M 20.19 M 23.17 M
Current Assets 50.89 M 37.65 M 44.28 M 46.96 M 48.05 M
Current Liabilities 27.22 M 22.31 M 19.61 M 25.73 M 25.20 M